Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Personally I’m glad that this protracted saga with Sierra has ended. They had no intention of taking that next step forward with 737, hence the stalling and dithering by Dilly and co. 737 should have been treating patients by now, and that is the major disappointment (how many lives lost?). Who knows what politics got in the way but that now lies in the past. Now there is a great opportunity if CRT and Sareum can progress this relatively quickly, in that respect nothing has changed. We still have 3 compounds that can make a difference to many thousands of people. Come on Tim and the team, just do it??
I’m sure there were some posts here last week, where have the gone?
They weren’t ver complimentary which is no surprise really!
Even with the ATOM spinoff many investors are still underwater and a long way from break even. This is the truth for PL to understand and resolve.
If GSK do take on 737 and develop it further, it will provide SAR with a valuable source of income. This income would easily fund current and future products. At this point the big Pharmas have a conundrum to solve, buy the lot or pay much more over the longer term, albeit in smaller chunks.
GLA
Stay positive and don’t sell out cheaply.
If you can’t buy and there is no stock available, you will have to wait until the MM’s hatch a plan to make some kind of market. Stop loss raid, followed by a price hike, then some profit takers and exciters, rinse and repeat until news. Tricky time though, FOMO syndrome and all that.
One thing is for certain, they are not having mine!
It’s a bit of a joke already, what happened to, and where is the information regarding deferred shared at the point of consolidation?
Bloody shambles PL, now over 60% down on my investment and that includes the positive from atom!
The problem is that we were expecting good results backed up with a better update and trading statement. Unfortunately neither has occurred hence the 20% drop!
This has got to get better, too much of a loss now to sell, in it for the long term whatever the outcome.
I don’t often post such bold statements but I have been adding over the last few months, averaging up! I’m sure that many LTH’s know the potential here and have done the same. The last RNS provided additional validation of our molecules and added value in the longer term. The sideways tracking SP with occasional dips is nothing but the MM’ s doing what they can to earn their crust. Just hold on to your golden shares and wait for the inevitable.
GLA
Even with the bonus of Atome, most people will have significant losses. Personally I don’t like consolidations and don’t feel that doing this will enable me to recoup that loss. Sell or hold, that is the choice! Does anyone think that the future will be better by holding? Hoping that Paraguay may offer a chance, but would prefer that to happen before any consolidation.
Gents, interesting to see the range of expectation for various assets. I’m sure the BOD have a figure in mind regarding the worth of each molecule and the company as a whole. They obviously won’t share that with shareholders but make no mistake they do have a price, it just needs an interested party to find out what that might be.
GLA